Galapagos and Cystic Fibrosis Foundation Therapeutics Sign €1.3 million* Agreement
Site Search
Showing 1 - 10 of 12 results
Press Release
|
April 14, 2005
|
4 min read
Cystic Fibrosis Foundation Therapeutics to Provide Alnylam with $1.5 Million in Funding for Discovery Efforts
Press Release
|
March 16, 2005
|
5 min read
Press Release
|
Jan. 12, 2006
|
6 min read
Press Release
|
Feb. 14, 2006
|
3 min read
Press Release
|
Jan. 23, 2008
|
6 min read
Press Release
|
July 8, 2008
|
5 min read
Press Release
|
July 16, 2008
|
5 min read
Press Release
|
Dec. 10, 2014
|
3 min read
Expanded Research Lab to Apply Latest Scientific Advances -- Including Stem Cell Research and Gene Editing -- to Accelerate New Treatments for CF
Press Release
|
Sept. 16, 2016
|
3 min read
Cystic fibrosis affects people of every racial and ethnic group. Of the nearly 40,000 people living with CF in the U.S., approximately 15% are identified as racially or ethnically diverse. Research shows that people of color with CF, particularly people who are Black and Hispanic, experience unique challenges and often have negative experiences that can lead to poorer outcomes. Some of these inequities are referenced in the following data.
4 min read